Dental Bone Articles & Analysis: Older
2 news found
RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive ...
This grant, the largest it has received from the Resource Center, will allow the company to conduct a pivotal animal study and generate all the other required data to file an Investigational Device Exemption (IDE) application with the FDA to start a clinical trial. "Unlike most existing dental bone graft materials, this enhanced formulation of Tetranite resorbs ...